MedTrace Logo

Rise Study for Depression

NCT06003361 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2024-01-17

No results posted yet for this study

Summary

This study will examine the efficacy of digital CBT versus waitlist in improving symptoms for adults with Major Depressive Disorder.

Conditions

Interventions

DEVICE

Digital CBT

An app-based intervention based on principles from cognitive behavioral therapy for depression.

OTHER

Waitlist

Participants will wait for 5 weeks prior to receiving the intervention

Sponsors & Collaborators

  • Big Health Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2023-11-22
Completion
2023-12-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06003361 on ClinicalTrials.gov